Patents

US 10934283 B2: COMT inhibiting methods and compositions

Granted
2021-03-02
Filed
2016-11-25 application 15779340
Type
Utility · 71 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Compounds that inhibit COMT enzyme and pharmaceutical compositions comprising the same are provided herein. Methods of treating various psychiatric and neurological disorders with the compounds and pharmaceutical compositions described herein are also provided.

Source: PVGPATDIS, file of 2026-04-10 (ipg210302.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Lieber Institute, Inc. 9 patentsUS company or organizationBaltimore, MDLIEBER INSTITUTE INC Nonprofit EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
James C. BarrowArnold, MD29PVGPATDIS, file of 2026-04-10
Glen ErnstBear, DE11PVGPATDIS, file of 2026-04-10
Dominique SwinnenBraine-l'Alleud, BE21PVGPATDIS, file of 2026-04-10
Florian MontelMeitingen, DE5PVGPATDIS, file of 2026-04-10
Sabine DefaysTubize, BE3PVGPATDIS, file of 2026-04-10
Yifang HuangLansdale, PA15PVGPATDIS, file of 2026-04-10
Pablo de LeonBaltimore, MD7PVGPATDIS, file of 2026-04-10
Michael S. PoslusneyOwings Mills, MD16PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D471/04PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/165PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2020-12-28Name change
Change of name
LIEBER INSTITUTE FOR BRAIN DEVELOPMENT signed 2011-08-30LIEBER INSTITUTE, INC. BALTIMORE, MD54857/413ECORSEXC, file of 2026-09-25
2018-06-13Assignment
Assignment of assignor's interest
BARROW, JAMES signed 2018-05-31
DE LEÓN, PABLO signed 2018-05-31
HUANG, YIFANG signed 2018-05-31
POSLUSNEY, MICHAEL signed 2018-05-31
ERNST, GLEN signed 2018-06-04
LIEBER INSTITUTE FOR BRAIN DEVELOPMENT BALTIMORE, MD46077/522ECORSEXC, file of 2026-09-25
2018-06-13Assignment
Assignment of assignor's interest
UCB BIOPHARMA SPRL signed 2018-05-31LIEBER INSTITUTE FOR BRAIN DEVELOPMENT BALTIMORE, MD46077/335ECORSEXC, file of 2026-09-25
2018-06-13Assignment
Assignment of assignor's interest
MONTEL, FLORIAN signed 2018-05-30
DEFAYS, SABINE signed 2018-06-06
SWINNEN, DOMINIQUE signed 2018-06-06
UCB BIOPHARMA SPRL BRUSSELS46077/151ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.